Quick Answer
Sanara MedTech Inc. reported Stockholders Equity of $5.94 million for fiscal year 2025.
Sanara MedTech Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $5.94M | -84.9% |
| 2024 | $39.40M | -12.1% |
| 2023 | $44.83M | +7.2% |
| 2022 | $41.83M | +36.5% |
| 2021 | $30.64M | +398.2% |
| 2020 | $6.15M | -7.0% |
| 2019 | $6.61M | +1027.2% |
| 2018 | $586.8K | +472.3% |
| 2017 | $102.5K | +124.2% |
| 2016 | -$423.1K | +66.7% |
| 2015 | -$1.27M | -54.0% |
| 2014 | -$825.4K | +66.6% |
| 2013 | -$2.47M | +35.1% |
| 2012 | -$3.81M | +1.4% |
| 2011 | -$3.86M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.15M | -84.5% | -82.6% |
| June 30, 2025 | $35.40M | -15.1% | -3.5% |
| March 31, 2025 | $36.67M | -15.3% | -6.9% |
| December 31, 2024 | $39.40M | -12.1% | -1.0% |
| September 30, 2024 | $39.78M | -10.2% | -4.6% |
| June 30, 2024 | $41.71M | +1.4% | -3.7% |
| March 31, 2024 | $43.29M | +4.0% | -3.4% |
| December 31, 2023 | $44.83M | +7.2% | +1.2% |
- Sanara MedTech Inc. showed a decrease of -84.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, Sanara MedTech Inc.’s stockholders equity has grown by 253.8% (from -$3.86 million to $5.94 million).
- The most recent figure is from Sanara MedTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: